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Abstract
Background: Cardiovascular disease, including atherosclerotic cardiovascular disease (ASCVD), is a growing public health
threat globally and many individuals remain undiagnosed, untreated, and uncontrolled. Simultaneously, mobile health (mHealth)
interventions using short messaging service (SMS) have gained popularity globally. There is an opportunity for innovative
approaches such as mHealth to encourage and enable adherence to medications for ASCVD and its risk factors.
Objective: This study aimed to understand mobile technology acceptance, use, and facilitating conditions among the study
population ahead of the design of an mHealth intervention.
Methods: Using data from a mixed-methods study conducted in Singapore, we conducted a cross-sectional survey with 100
participants and in-depth, semistructured interviews with 20 patients. All participants were over the age of 40 years with ASCVD
or its risk factors. Interviews were conducted in English and Mandarin and if needed translated to English. Nvivo 11 (QSR
International) was used for analyses.
Results: Participants reported their perspectives on technology use and preferences, including low or sporadic mobile phone
use and usability concerns including small screen and text size, among others; the benefit of previous mHealth use in creating a
favorable opinion of SMS for health information; trust in both the source of mHealth SMS, as well as in treatment; the formation
of habits; and fear of sequelae or death for facilitating intention to use an mHealth intervention and adhere to medication. We
also highlighted a case that underscored the importance of the period after diagnosis in habit forming as an opportunity for an
mHealth intervention.
Conclusions: We explored both technology- and adherence-related factors that influence a patient’s intention to use an mHealth
intervention for adherence to ASCVD medication in Singapore. We highlighted the importance of identifying the right opportunity
to engage with patients and promote an mHealth intervention for adherence, such as immediately following diagnosis when
patients are establishing medication-taking habits.
(JMIR Mhealth Uhealth 2019;7(3):e11108)   doi:10.2196/11108
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Introduction
Background
Mobile health (mHealth) interventions using short messaging
service (SMS) have gained popularity as the number of people
using mobile technology increases globally [1]. Singapore has
one of the highest mobile phone penetration and usage rates in
the world, thus providing an interesting case study for such
interventions [2]. SMS-based interventions have shown promise
because of affordability and wide outreach and have been
applied to many aspects of health including health promotion
and to enable medication adherence [3-5]. Although mHealth
has provided many opportunities to reach patients, especially
vulnerable groups, it is important that contextually appropriate
patient preferences, usability, and acceptance of technology are
considered when undertaking these interventions.
Patient preferences and acceptance are of particular importance
when considering mHealth interventions for chronic conditions
such as cardiovascular disease (CVD). CVD, including
atherosclerotic cardiovascular disease (ASCVD), is a growing
public health threat globally, with mortality rates estimated to
reach 23.3 million by 2030 [6]. Importantly, many individuals
with risk factors for ASCVD remain undiagnosed, untreated,
and uncontrolled [7,8]. This points to the need for greater
attention to factors impacting adherence in these patients and
innovative approaches, such as mHealth, to encourage and
enable adherence to medications for ASCVD and its risk factors
in this patient population.
A systematic review demonstrated evidence of the feasibility
of mHealth for adherence to medications for CVD. All 10
completed trials included in the review showed improved
medication adherence for patients with CVD; all studies also
reported positive responses to mHealth use from patients,
however, the authors highlighted the paucity of data on studies
including user input on the design of the intervention [9].
Qualitative studies have also shown the potential of mHealth
to provide education, optimize resources, and improve use of
health care for CVD management [10]. Yet, there is a need for
more contextual evidence on patient acceptance and use of
mHealth interventions for adherence, specifically exploring the
unique factors that influence the use and acceptance of mHealth
adherence support for medications to treat chronic conditions.
For example, elderly patients managing chronic conditions may
face unique usability concerns including functional difficulties
using the device, limitations in vision and hearing, as well as
the need for appropriate message content [11]. To explore the
needs of those with or at risk for ASCVD in Singapore, our
study population comprised patients over the age of 40 years
identified as having ASCVD, or risk factors for ASCVD
including hypertension or hyperlipidemia.
This study is the development phase of a proposed mHealth
intervention, the txt2heart trial, to support patient adherence to
medications for ASCVD. The txt2heart trial is an international
collaboration evaluating the efficacy and safety of SMS on
clinical outcomes and adherence in different countries including
Colombia, Ghana, India, and Singapore. This study sought to
explore mobile technology acceptance, use, and facilitating
conditions, as well as adherence factors, among the Singapore
study population ahead of the design of the mHealth
intervention.
The Study Setting: Singapore
To better contextualize our findings, it is necessary to consider
larger health system factors relevant to Singapore, primarily the
ubiquity of affordable and accessible health care. Singaporeans
have access to largely subsidized care offered in polyclinics
(government subsidized general practice clinics), private general
practitioners, and tertiary care facilities for primary care and
chronic condition management. Furthermore, within the primary
care setting, doctors regularly prescribe months’ worth of
medications, thus enabling ease of access to medications. The
government also provides subsidies and various schemes for
the management of chronic conditions; the majority of our
participants reported availing these schemes to pay for their
health care and most reported being able to afford and access
their CVD medications.
Theoretical Framework
Using a deductive approach, we used the unified theory of
acceptance and use of technology (UTAUT) model to analyze
our qualitative findings. This was then complemented by
emergent themes on medication adherence factors, which
prompted us to apply the World Health Organization (WHO)
adherence model to our data [12]. We then applied the modified
and condensed UTAUT model to understand technology
acceptance and use among participants with ASCVD and
ASCVD risk factors (Figure 1). The UTAUT has been widely
used to understand information technology (IT) adoption in
general and has also been applied to health IT [13-17].
The UTAUT model employs 4 constructs through which to
explore user factors; these being (1) performance expectancy,
(2) effort expectancy, (3) social influence, and (4) facilitating
conditions. Performance expectancy includes the perceived
usefulness and personal outcome expectations associated with
technology use. Effort expectancy is the perceived ease of use
and complexity of the technology. Social influence includes
subjective norms and technology use within a user’s social
milieu, whereas facilitating conditions include perceived
behavioral control and wider contextual circumstances that
support the use of technology. We have labeled these as
technology-oriented factors as they explore the users’ experience
and preferences as oriented to their use and acceptance of
technology.
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Figure 1. Modified unified theory of acceptance and use of technology model for adherence factors adapted from Venkatesh (2003) and World Health
Organization (2003).
Underpinning these constructs and impacting them in multiple
complex ways are the influence of person-oriented factors
including gender, age, socioeconomic factors, experience, and
voluntariness of technology use. The confluence of these factors
ultimately impacts one’s behavioral intention and use behavior
as well as the actual use of the mobile technology or
intervention.
An important modification necessary to understand use and
acceptance of an mHealth intervention for adherence is the
adherence factor, which may contribute to the behavioral
intention and use of the intervention [18]. For our purposes, we
have adapted the WHO framework to focus on the
condition-related and therapy-related factors impacting
adherence. Condition-related factors are the illness-related
demands faced by the patient, which ultimately impact a
patient’s risk perception, treatment beliefs, and the priority they
place on adherence [18]. Therapy-related factors include side
effects, treatment duration, treatment failures, and experience
of side effects [18]. Although an intervention may meet the
technology-oriented needs of a patient, the lived experience of
their condition(s) and treatments could present barriers to their
behavioral intention, both to adhere to treatment as well as to
use an mHealth intervention to support treatment adherence.
In this study, we explore in detail the technology-oriented
aspects of UTAUT as well as therapy- and condition-related
adherence factors acting upon a patient’s behavioral intention.
Thus, we use the modified and condensed UTAUT model and
key elements of the WHO framework as a way to better
understand the factors impacting elderly Singaporeans’
acceptance and use of mobile technology for an intervention to
support adherence to ASCVD medication.
Methods
Sampling (Survey)
This cross-sectional component utilized data from a brief locally
adapted survey created for this study, which sought to explore
patient technology use. The survey used purposive sampling of
an existing patient pool from the Singapore Population Health
Study—Community Health Study to recruit those aged 40 years
and above with established ASCVD or risk factors who fulfilled
inclusion criteria (Textbox 1).
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Textbox 1. Study inclusion and exclusion criteria.
Inclusion criteria:
• Patients with a history of ASCVD: coronary artery disease, ischemic stroke, peripheral artery disease, and atherosclerotic aortic disease; or
• At least one risk factor such as hypertension or hyperlipidemia in whom antiplatelet, antihypertensives, and/or statins are recommended.
Exclusion criteria:
• Participants unable to participate in a verbal interview;
• Participants who did not speak Mandarin, English, or Malay languages.
Both the survey and interview guide were developed as part of
the larger txt2heart collaboration, which we then adapted to the
Singapore context and covered topics including patients’
sociodemographic characteristics, health care access, medication
adherence, mobile phone technology usage (ownership, access,
and utilization), and interest in mHealth (Multimedia Appendix
1).
Sampling (Qualitative)
The study took place in Singapore. We used purposive sampling
from an existing patient list to recruit those aged 40 years and
above with established ASCVD or risk factors for ASCVD (for
complete inclusion and exclusion criteria, see Textbox 1).
Survey, Interviews, and Interview Guide
Trained research staff from the National University of Singapore
(NUS) conducted the interviews or semistructured in-depth
interviews in the participant’s preferred language by staff fluent
in that language. Interviewer training included description of
research protocol, qualitative methods, and research ethics in
practice.
Participants
The qualitative component involved semistructured in-depth
interviews with 20 participants. Out of the 20 participants
interviewed, 19 agreed to audio recording and 1 participant
declined. For the latter, detailed field notes and an extensive
memo were taken for inclusion in data analysis.
A total of 100 patients met the inclusion criteria for the
quantitative survey and were recruited over the telephone. In
total, 60 in-person and 40 telephone surveys were completed
following informed consent from patients. A total of 100
surveys, inclusive of 1 incomplete survey on mobile phone
technology usage section, assessed patients’ sociodemographic
characteristics, pattern of medication adherence, mobile phone
technology usage (ownership, access, and utilization), and
interest in mHealth.
Ethical Approval
Ethical approval for the study was obtained from the NUS
Institutional Review Board. Informed consent for participation
and recording was obtained before the interview started using
a participant information sheet and consent form. Participants
could refuse to answer any of the questions and/or discontinue
their participation in the research at any time.
Statistical Analysis
Statistical analyses were performed using IBM SPSS version
24.0 (IBM Inc). Frequencies (n) and percentages (%) were used
to summarize sociodemographic characteristics, clinical
characteristics, patterns of mobile phone technology usage, and
interest in mHealth.
Qualitative Analysis
A total of 2 research team members coded interviews using
Nvivo 11 (QSR International) software applying interpretive
and inductive approaches, thematic analysis, and techniques
from the constant comparative method, where a line-by-line
analysis of early interviews was used on subsequent interviews
to test preliminary assumptions [19]. Interviews were recorded
and transcribed in full. Reviewers agreed on identified codes
and themes. To maintain confidentiality, all names reported
were pseudonyms and identifying data were excluded.
Results
Participant Characteristics
The mean age of the 100 participants in the analysis sample was
65.3 (SD 9.6) years (Table 1). The largest proportion of
participants, 55% (55/100), encompassed those aged greater
than or equal to 65 years. The majority of patients (70/100,
70%) were male and 66% (66/100) were of Chinese ethnicity,
with women and Malay, Indian, and other ethnicities
representing a smaller proportion of the sample. Moreover, the
majority of patients, 72% (72/100), reported having
hyperlipidemia and 68% (68/100) reported having hypertension.
We conducted 20 in-depth interviews with participants who met
the inclusion criteria. The detailed characteristics are presented
in Table 2. Participants were largely of Chinese ethnicity (15/20,
75%) with fewer participants from Indian (4/100, 20%) and
Malay (1/20, 5%) ethnic groups. Participants were mostly male
(12/20, 60%) with 8 (8/20, 40%) female participants. The
average age of participants was 72.5 years. The majority of
participants (19/20, 95%) reported a hypertension diagnosis,
followed by hyperlipidemia (16/20, 80%) and myocardial
infarction/acute coronary syndrome (8/20, 40%) and
stroke/transient ischemic attack (5/20, 25%).
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Table 1. Quantitative participant characteristics table (n=100).
Total (n)Sociodemographic characteristics
Ethnicity
66Chinese
19Malay
14Indian
1Other
Gender
70Male
30Female
Age (years)
45<65 years old
55≥65 years old
Cardiovascular conditions
72Hyperlipidemia
68Hypertension
41Myocardial infarction or acute coronary syndrome
14Stroke or transient ischemic attack
Table 2. Qualitative participant characteristics table (n=20).
Total (n)Sociodemographic characteristics
Ethnicity
15Chinese
4Indian
1Malay
Gender
12Male
8Female
Age (years)
761-70
871-80
481-90
1Missing
Cardiovascular conditions
19Hypertension
16Hyperlipidemia
8Myocardial infarction/acute coronary syndrome
5Stroke/Transient ischemic attack
Quantitative Survey Results
A quantitative survey of 100 patients meeting the same criteria
outlined above provided our study with descriptive data on our
target population. Of the 99 participants who fully completed
the survey, 90% (90/99) owned a mobile phone. Of those mobile
phone owners, 77% (70/90) reported accessing their mobile
phones in general at least once a day, and the same proportion
of patients (70/90, 77%) reported using SMS at least once a
day. In general, participants predominantly used their phones
for phone calls (87/90, 97%), SMS (60/90, 65%), and other text
messaging services such as Whatsapp (54/90, 61%; Figure 2).
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Figure 2. Phone usage activities amongst mobile phone owners.
Figure 3. Preferred channel of delivery for mobile health intervention. mHealth: mobile health.
Of those who owned a mobile phone, 53.3% (48/90) indicated
their interest in receiving medication information through their
mobile phones.
Among those interested in mHealth services, SMS was the
preferred mode of delivery of information on medication for 40
out of 48 participants (83%), followed by other text messaging
services (33/48, 68%), phone calls (32/48, 66%), social media
such as Facebook and email (15/48, 31%; Figure 3).
Qualitative Interview Findings
We reported our findings classified into themes based on our
modified UTAUT model. In terms of technology-oriented
factors, the first theme explored perceived usefulness of the
mHealth intervention and personal outcome expectations. The
second theme explored effort expectancy, including perceived
ease of use, as well as other usability issues experienced by our
elderly population. Next, we explored the social influences
shaping technology use including the role of family and friends,
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as well as the impact of social isolation. Then we looked at
facilitating conditions for technology use including trust and
previous mHealth use. We next explored adherence factors
influencing behavioral intention, including therapy-related
factors such as regime complexity, therapy duration,
inconvenience, and adverse effects. Finally, we looked at
condition-related factors including symptoms and effects of
condition on the functional and mental state. See Multimedia
Appendix 2 for key themes and examples of evidence.
Perceived Usefulness
Participants reported on their perception of the usefulness of
having a reminder system to take their medications. Most
participants reported that they saw no need for such a system,
as they did not have difficulties remembering. As Yong Liat
reported:
I can’t forget. Every time I put it on top, and I write
down there. So I know. People don’t need to tell me.
I know myself. [IDI006_M_81-85_Chinese]
However, some participants did agree that hypothetically having
reminders may be good for others who forget to take their
medications. As Kim Huat explained:
They should see the message and it should help. After
all the reminder for them to take the medication is
actually beneficial for them, and they should heed the
reminders. [IDI009_M_71-75_Chinese]
Some participants also voiced that low phone usage may inhibit
the usefulness of an SMS intervention. As Irene described:
I don’t look at my phone...when the phone beeps with
an SMS I’ll think of checking it later, but I’ll forget.
Do you see how many unread and unanswered SMSes
and WhatsApp message I  have?
[IDI004_F_66-70_Chinese]
Personal Outcomes Expectations
The majority of participants explained that they personally felt
an SMS intervention would not be useful or provide a useful
outcome. This is partly because of some participants having
low reliance on their phones, meaning the vehicle for delivery
may not be aligned with the population’s mobile uses.
Furthermore, some participants expressed that the intervention
does not address what they perceive to be the root causes of
nonadherence, which they feel to be beyond the reach of
mHealth. For example, an SMS intervention would not help
those who intentionally do not take their medication. As Ah
Siew explained:
If they want to take medication, they will. Some people
they’re not taking it on purpose. I don’t take some of
my medication too. We take only the important
medicine and don’t take those that we feel aren’t
important. [IDI020_F_71-75_Chinese]
Another participant highlighted that regardless of the proposed
intervention, a key factor in adherence is patient agency and
responsibility in placing importance on their health. Yan Ting
explained:
I think whatever method you want to use, it's nothing
compare to convincing that patient that it is in their
own interest and it is important for them to take the
medicine regularly according to the schedule... I think
if they are serious looking after themselves, it becomes
a habit already. [IDI018_M_76-80_Chinese]
However, some participants reported on factors that may be
modifiable by an mHealth intervention. Irene summed up her
perspective of the main factors for nonadherence, forgetfulness,
dependency on others, and being busy:
Interviewer: How do you think we can use mobile
phones to remind people to take their medication?
Participant: When people forget to take their
medications it’s the following three reasons. First,
they’re forgetful, like me. I tell myself it’s time to take
my medication and walk to the kitchen. When I’m in
the kitchen, I can’t remember why I came into the
kitchen. Second, they’re dependent. They wait for
people to tell them. Third, they are too busy. Just these
three types of people. [IDI004_F_66-70_Chinese]
Effort Expectancy
As mHealth interventions predicate on patients being able to
interact with SMS, it is important to understand their perceptions
of basic mobile technologies as well as their perceptions on
their ability to learn how to use such technologies.
Perceived Ease of Use
Some participants described difficulty using a mobile phone,
thus preventing them from being interested in an mHealth
intervention. However, others were keen to keep up with
technology and expressed initiative and interest in learning
about their phones. Safiah explained how she previously did
not know how to use some features of her phone, but now is
able to:
Previously I SMS right-- previously aunty don’t know
how to SMS...So now everything I know. You live in
the world of today...Every now and then, you must go
out and learn everything. What the youngsters can
do, the old also can do. [IDI012_F_71-75_Malay]
Among those who are comfortable using technology, a few
reported that SMS is a good and convenient way to convey
health information:
It’s also good via SMS or WhatsApp since it’s more
convenient and the information is in the phone.
Sometimes we might not have time to answer a call.
[IDI009_M_76-80_Chinese]
Usability Issues
Many participants, however, reported on functional issues
preventing them from comfortably using a mobile phone
including small screens or font sizes that are barriers to reading
SMS messages. As Cheng Han explained:
Our eyesight is also failing. Sometimes we see an“8”
as an “S.”It also makes it difficult to read our SMS.
Our senses all deteriorate after 70 years old.
[IDI014_M_71-75_Chinese]
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Another usability concern raised by many participants was that
of the language of intervention. Most participants agreed the
SMS reminders should be sent in local languages. As Kim Huat
reported:
It would help if it’s in Chinese, Malay, Tamil. Those
of us who are older don’t understand English, and
t h u s  t h e  c o n t e n t  i n  t h e  S M S .
[IDI009_M_76-80_Chinese]
While Sow Tin explained that some older people had lower
literacy and thus require simplified SMS content:
Firstly, I didn’t really go to school. So I can only read
really simple English and Chinese. I can speak better,
but not write...I will just reply “Ok.” If I don’t know
how to text back my response, I will send them a voice
m e s s a g e .  I t ’s  e a s i e r  l i k e  t h a t .
[IDI004_F_66-10_Chinese]
Social Influence
Another important component of technology uptake and use is
that of social influence. Those with stronger social networks
who use and look favorably on technology may use technology
to connect and stay in touch, and these networks may in turn
enable them to adopt technology.
Family and Friends’ Technology Use
Some participants reported that the lack of a social support
system is a reason for not being interested in using a mobile
phone, and others reported using the phone less as their friends
had passed away. As Wen Cheng explained:
I don’t have many friends. I don’t need to talk a lot
now, or I just use the home telephone.
[IDI001_M_71-75_Chinese]
Among those who had stronger social supports, many described
that their friends were an important factor in their ability to learn
and keep up with technology. Others described how technology
had enabled them to keep in touch with friends from abroad and
that these groups were helpful to them, thus giving them a
favorable impression of mobile technology. One participant
described how technology and social support played a role in
adherence. As Kavita reported:
She (friend) every time calls me, you know, because
she know I forget.“Hey, take medicine already?”She
don’t know which medicine I take but she give me a
reminder. [IDI013_F_61-65_Indian]
Facilitating Conditions
Our participants highlighted the importance of previous exposure
to mHealth services and trust as facilitators to mHealth use.
Previous Mobile Health Use
A majority of participants reported positive experiences with
previous mHealth apps, namely SMS appointment reminders.
Participants felt these were useful and helped them to remember
their appointments. Kim Huat explained:
They will send SMS to me, and they also give me a
paper with the appointment date. They usually remind
me via SMS a week before my appointment...It’s a
good reminder so that you don’t forget.
[IDI009_M_76-80_Chinese]
One participant, Kamal, highlighted that patients may not be
an appropriate audience to target the SMS reminders to and it
would be more useful to engage primary caregivers in mHealth
interventions:
Tell the person looking after the patient to remind
them to take their medication...The person cannot
remember...so if you tell the children or (caregiver)
they will make sure they take the medication, as if the
orders come from the doctor the caregiver will scared
and make sure they take. [IDI010_M_71-75_Indian]
Trust
An important facilitating factor reported by patients was that of
trust. Some patients explained that they do not trust all the
information they reiceve on the Web or shared through
Whatsapp groups. As Kim Huat said:
There are a lot of fake information there (on the
phone), not all are true. [IDI009_M_76-80_Chinese]
Thus, highlighting the need for an mHealth intervention to come
from a trusted and known source.
Kim Huat went on to explain how the underlying trust in
treatment is important in an mHealth intervention for adherence
to medications:
Interviewer: Who do you think this service will help?
Participant: Those that believes that their medication
is effective. After all if you face any issues while taking
the medication, the doctor and change it for you.
[IDI009_M_76-80_Chinese]
This highlighted the need to not only understand user
preferences and behaviors, but also to take into consideration
the various adherence factors, which influence patient decision
making and ability to adhere to medications.
Adherence Factors
Adherence factors include therapy-related and condition-related
factors. To design an appropriate mHealth intervention, it is
important to understand how both the medication itself and the
condition may limit or enable adherence to medication.
Therapy-Related Factors
Complexity of Medication Regime
Some patients reported adjusting their medication to cope with
a complex regime and to facilitate their ability to adhere to their
medications. As Sow Tin described:
The doctor did tell me to take the blue pills before
food. I thought it was troublesome to split them, so I
took all my pills before food. So I can remember
whether I’ve taken my medication...The doctor did
say I was cheating. But it’s okay. It’s more time
efficient for me. [IDI004_F_66-70_Chinese]
Nearly all patients described how using a pillbox and the ritual
surrounding taking their medication had enabled them to form
habits. Patients also reported that they did not feel the need to
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have an mHealth intervention to remind them as their current
habits and pillbox use enabled them to ensure they had taken
medications and prevented them from taking a double dose.
Duration of Therapy
The majority of patients also reported how the long duration of
therapy for chronic conditions facilitated their ability to adhere
to their medications. Thus, they felt that an mHealth intervention
would not be of use, as they had already established habits over
the course of managing their chronic conditions. As Karen
reported:
I just follow...because I have been using it for long,
it’s no problem to me...It’s all very systematic. No
problem. [IDI003_F_NA_Chinese]
Inconvenience With Lifestyle
Although most patients reported that they largely adhered to
their medications and had habits to support their medication
taking, some patients reported how lifestyle factors disrupted
their routines on occasion. Largely, patients reported how going
out of the house or travelling was disruptive. As Ah Siew
described:
But if I go out, I won’t bring and eat it. It’s very
troublesome to take it when I’m on the bus or (train).
I’ll just miss taking it. For instance, I went to Ipoh
Malaysia the other day, I brought my medicine but I
didn’t take it for two days, as it’s too troublesome.
[IDI020_F_71-75_Chinese]
Adverse Effects
Some patients reported how adverse effects caused them to be
nonadherent to their medications. One participant reported that
while the doctor wanted to titrate the dose, he decided to stop
entirely. As Yong Liat reported:
Just recently. Because I told the doctor, I feel giddy
then doctor say maybe this one caused...he asked me
t o  t a k e  h a l f . . . s o  I  s t o p p e d .
[IDI006_M_81-85_Chinese]
Condition-Related Factors
Patients reported few condition-related factors as impacting
their ability to adhere to their medications for ASCVD and its
risk factors. One patient reported being prescribed various doses
of medication and not taking it unless his blood pressure was
high. As Cheng Han described:
Yes. I may forget my blood pressure medications...For
blood pressure, I usually don’t take the medications
unless my blood pressure is high.
[IDI014_M_71-75_Chinese]
A few participants also reported how taking medications
impacted their mental state, as they felt fearful of sequelae or
death. For some participants, this caused them to titrate or
change medications. As Sow Tin described:
You see, this cholesterol medication was given to me
in March, and I still have so much leftover. If I show
the doctor, he/she is going to scold me. So I won’t tell
the doctor...My sister told me that if I take a lot of
these cholesterol medication, it will affect my kidneys.
So I’ve stopped taking that one and take this one
instead. I’m not as afraid of kidney trouble with this
one. [IDI004_F_66-70_Chinese]
Whereas, others reported that fear of disability and death
motivated them to continue their habits and be adherent to their
medications. As Yu Yan explained:
I take them right after washing my face as I scared I
forget...It’s okay to die, it’s not okay to be disabled.
So I take my medications...Because I’m scared to die,
it motivates me to eat my medication, without even
any reminder. [IDI008_F_71-75_Chinese]
The Learning Curve and Mobile Technology
One participant highlighted in detail the learning curve after
diagnosis and commencement of treatment as a potential
opportunity for mHealth interventions for adherence to
medications (Textbox 2).
This case explored how the uncertainty of a new diagnosis and
discharge from hospital care is an opportunity for mHealth to
provide adherence support to patients where they have a high
intention to uptake adherence behaviors. Patients who have
managed their chronic conditions for years may not be as
receptive as they have established habits; however, newly
diagnosed patients or newly discharged patients may be primed
to receive support in their care.
Textbox 2. Case study on the learning curve.
David, a 64-year-old male, had no history of heart disease before having a severe heart attack, which required the insertion of a left ventricular assist
device. He was admitted to the intensive care unit for over a month before being discharged. While in hospital, David reported being on 14 different
types of medication, which were reduced to 11 upon discharge after he reported adverse side effects. Presently, he is only on 2 medications. David
explained the role of his care coordinators, who taught him about his medications before discharge. He also explained how they interceded on his
behalf with the doctors to reduce the number of medications he was prescribed. Importantly, he described how they were available to call or SMS
when he had questions. When asked about the use of an mHealth intervention to remind patients to take their medications, he explained: “It will be
useful for patients who just came out of the ward. But not for long-term patients, because we know what to do.” [IDI007_M_61-65_Indian]; David
reported that in the days following discharge, the care coordinators would check in daily and ask on his adherence and other required activities (dressing
changes, etc); and now they check in every 2 weeks, and he is able to reach out to them should he require their assistance.
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Discussion
Principal Findings
This mixed-methods study explored mobile technology
acceptance, use, and facilitating conditions, as well as adherence
factors among older Singaporeans ahead of an mHealth
intervention to promote adherence to ASCVD medications.
Participants reported variable acceptance of mobile technology.
Some participants were tech savvy and used mobile technology
regularly and broadly to connect with their social networks,
whereas others reported decreasing social connectedness as a
reason for not using mobile technology. Participants widely
reported usability concerns including reading difficulty because
of screen and font size and hearing difficulties limiting their
awareness of notifications. This is in line with other research
on mobile technology use for health interventions with older
participants [20]. These technology-oriented factors have an
impact on user’s behavioral intention to use technology, as well
as their intention or interest in using an mHealth intervention
for adherence to medications. Indeed, among our study
population, whose mean age was 72 years for the qualitative
component, participants were largely disinterested in SMS
reminders, often citing low mobile phone usage or usability
concerns as a barrier to uptake.
Suboptimal adherence to medications for ASCVD and its risk
factors is well documented [6,21-23]; however, most of our
participants reported not needing reminders to take their
medication as they have their own established habits and report
themselves as being adherent. Yet, some participants reported
self-titration and nonadherence when lifestyle factors interfered
with their ability to have medications on hand. Thus, caution is
warranted in these self-reports of adherence. These reports of
adherence may impact patients’ behavioral intention to use an
mHealth intervention, as many participants reported no interest
in an mHealth intervention for adherence to medication, as they
did not see personal benefit to such a service.
Despite these concerns, some participants did report that SMS
was a good avenue through which to receive health information.
This is in line with findings from other studies across health
research where it has been shown that despite perceived usability
issues or dissatisfaction with available options, patients believe
in the capacity of mHealth interventions to facilitate better health
outcomes [24-27]. In our study, a contributor to a favorable
opinion of the proposed intervention was previous mHealth use.
Participants who received appointment reminders from health
care providers were more open to the idea of health content
delivered through SMS, although they were ambivalent on the
utility of medication reminders.
Another factor facilitating a positive perception of mHealth was
that of trust; both trust in the SMS sender, and trust in the
treatment plan. Participants described caution in believing
Web-based sources for health information, reported receiving
spam SMS messages, and underscored the importance of
wanting a trusted source for any mHealth SMS. Other studies
have shown that trust is an integral part of intent-to-use
technology and predicates on the belief that the other party will
not exploit the vulnerability of the user [28,29]. Participants
also linked the success of any mHealth intervention to whether
patients trusted their medications. There is ample evidence on
the role of trust, both in treatment and in provider, in medication
adherence [30-32], and these facets of trust in treatment are
important in establishing the behavioral intention to use an
mHealth intervention for adherence to medication.
Although technology-oriented factors directly influence a
patient’s ability and motivation to use and follow an mHealth
intervention, adherence factors also play a role in determining
if a patient is able to translate the behavioral intention triggered
by the SMS into a use behavior. The use of habits and reminders
is well documented in facilitating adherence to medications
[33-35]. Our study adds to this evidence showing that patients
perceive they are able to cope with treatment complexity by
establishing their own habits and rituals and that given the length
of treatment required they become accustomed to taking their
medications. Importantly, however, patients did report
self-titration because of adverse effects, as well as lifestyle
factors that disrupted their ability to adhere to medications.
These are important factors that may not be modifiable by an
mHealth intervention but warrant consideration.
The unique case of David highlights the importance of the
learning curve wherein patients develop these habits and rituals
for medication taking. After diagnosis, patients may require
additional support and be open to receiving that support, as they
begin to develop habits and adopt behaviors relating to
medication taking and lifestyle adjustment. Although, as is the
case with David, this support may taper off over time once
adherence behaviors are established, or the perceived utility
diminishes. It also presents the opportunity to reintroduce the
intervention should new medications be introduced or the patient
requests additional support. Although technology-oriented
factors, adherence factors, and contextual factors may pose
challenges to uptake of an mHealth intervention, this case
highlights the importance of identifying opportunities where
the barriers to mHealth uptake may be lower as patients are
actively seeking support as they take ownership of their care.
Strength and Limitations
A strength of our study is the use of in-depth interviews for the
exploration of patients’ perspectives on both medication taking,
as well as technology use and the opportunities and challenges
for mHealth interventions. Furthermore, the inclusion of
participants from multiple ethnic backgrounds and older
participants adds to the diversity of experiences reported.
A limitation of this study is that it excluded individuals with
disabilities, which prevented them from participating in verbal
interviews. Also, our participants were all over 60 years of age,
thus we are not capturing the perspectives of those middle-aged
persons taking medications for ASCVD and its risk factors who
may have differing adherence patterns or mobile technology
use behaviors. The fact that Singapore has a high mobile phone
penetration rate, a small geographical size, and is a 100%
urbanized city-state may limit its generalizability to other
countries with differences in such characteristics. Furthermore,
contextually, health system factors in Singapore, including high
accessibility and availability of care may account for some of
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the patient accounts of not needing reminders, as they are able
to easily access follow-up care. Our study also did not include
caregivers, who may be a more appropriate end user for the
intervention, particularly among those older persons who rely
on caregivers for their medication taking. Furthermore, we relied
on self-reported adherence measures, thus some participants
may have reported higher adherence to medication. A final
limitation is that of desirability bias, whereby participants may
be reporting more favorably on their experiences.
Conclusions
Our study had identified several important technology-oriented
and adherence-related factors from the patient perspective that
warrant consideration in the design of an mHealth intervention
to support adherence to medications for ASCVD and its risk
factors in Singapore. We also highlighted the importance of
finding the right opportunity to engage with patients and
promote an mHealth intervention, such as immediately following
diagnosis when patients are establishing medication-taking
habits. As health care professionals increasingly leverage on
innovative approaches such as mHealth to promote adherence
to medications for chronic conditions, it will be important to
better understand both the technology-related behaviors that
impact a patient’s intention and ability to use an mHealth
intervention, as well as therapy- and condition-related factors
that may enable or inhibit successful adoption of such an
intervention.
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